SynthesisBMC cancer2026

A systematic review and meta-analysis of treatment-induced hypertension risks from androgen receptor pathway inhibitors in randomized controlled trials for prostate cancer.

Qianqian Gong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.